Literature DB >> 6307409

Male sexual development in the nonhuman primate. III. Sertoli cell culture and age-related differences.

B C Lee, J L Pineda, B E Spiliotis, T J Brown, B B Bercu.   

Abstract

Homogenous preparations of primary Sertoli cell cultures were obtained from the testes of the macaque of different ages. The characteristics of Sertoli cells were confirmed by electron microscopy. Sertoli cell cultures were segregated into three developmental age groups: prepubertal, pubertal, and adult. The highest response to follicle-stimulating hormone [FSH (NIH-FSH-S13) as measured by cAMP and testosterone to estradiol conversion occurred in Sertoli cells from pubertal animals, whereas the responses were diminished in cells from both younger and older animals. Specific binding of 125I-human FSH was also increased in Sertoli cells prepared from pubertal animals when compared to cells from the other two age groups. These data demonstrate: 1) the utility of primate Sertoli cells as an in vitro model, and 2) the age-related differences in monkey Sertoli cell response to FSH and to specific FSH receptor binding.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6307409     DOI: 10.1095/biolreprod28.5.1207

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  2 in total

1.  Insufficient androgen and FSH signaling may be responsible for the azoospermia of the infantile primate testes despite exposure to an adult-like hormonal milieu.

Authors:  Subeer S Majumdar; Kanchan Sarda; Indrashis Bhattacharya; Tony M Plant
Journal:  Hum Reprod       Date:  2012-06-04       Impact factor: 6.918

2.  Direct reprogramming of Sertoli cells into multipotent neural stem cells by defined factors.

Authors:  Chao Sheng; Qinyuan Zheng; Jianyu Wu; Zhen Xu; Libin Wang; Wei Li; Haijiang Zhang; Xiao-Yang Zhao; Lei Liu; Ziwei Wang; Changlong Guo; Hua-Jun Wu; Zhonghua Liu; Liu Wang; Shigang He; Xiu-Jie Wang; Zhiguo Chen; Qi Zhou
Journal:  Cell Res       Date:  2011-11-08       Impact factor: 25.617

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.